Summit Financial Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Summit Financial Wealth Advisors's LLY Position: Q2 2026 in Review
Summit Financial Wealth Advisors increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $199K and bringing the position to 1,335 shares worth $1.6M. The position accounts for 0.2% of the portfolio, ranked #63.
Summit Financial Wealth Advisors first reported a position in LLY in Q1 2015 and has held it in 16 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Summit Financial Wealth Advisors held 1,335 shares of Eli Lilly worth $1.6M as of Q2 2026.
- Summit Financial Wealth Advisors bought 195 Eli Lilly shares in Q2 2026, an estimated $199K.
- Eli Lilly made up 0.2% of Summit Financial Wealth Advisors's portfolio in Q2 2026, its #63 holding.
- Summit Financial Wealth Advisors first reported a position in Eli Lilly in Q1 2015 and has held it in 16 quarters since.
- 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Summit Financial Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.